These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 31605252)
1. Selectivity Enhancement of Paclitaxel Liposome Towards Folate Receptor-Positive Tumor Cells by Ligand Number Optimization Approach. Prajapati MK; Bishnu A; Ray P; Vavia PR AAPS PharmSciTech; 2019 Oct; 20(8):317. PubMed ID: 31605252 [TBL] [Abstract][Full Text] [Related]
2. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
3. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells. Tong L; Chen W; Wu J; Li H Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314 [TBL] [Abstract][Full Text] [Related]
4. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282 [TBL] [Abstract][Full Text] [Related]
5. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment. Song B; Wu S; Li W; Chen D; Hu H Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481 [TBL] [Abstract][Full Text] [Related]
6. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine. Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284 [TBL] [Abstract][Full Text] [Related]
7. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
8. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007 [TBL] [Abstract][Full Text] [Related]
9. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs. Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838 [TBL] [Abstract][Full Text] [Related]
10. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel. Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984 [TBL] [Abstract][Full Text] [Related]
11. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model. Ajorlou E; Khosroushahi AY; Yeganeh H Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study. Monteiro LOF; Fernandes RS; Oda CMR; Lopes SC; Townsend DM; Cardoso VN; Oliveira MC; Leite EA; Rubello D; de Barros ALB Biomed Pharmacother; 2018 Jan; 97():489-495. PubMed ID: 29091899 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes. Peres-Filho MJ; Dos Santos AP; Nascimento TL; de Ávila RI; Ferreira FS; Valadares MC; Lima EM AAPS PharmSciTech; 2018 Jan; 19(1):201-212. PubMed ID: 28681330 [TBL] [Abstract][Full Text] [Related]
14. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides. Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323 [TBL] [Abstract][Full Text] [Related]
15. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551 [TBL] [Abstract][Full Text] [Related]
16. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy. Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370 [TBL] [Abstract][Full Text] [Related]
17. K237-modified thermosensitive liposome enhanced the delivery efficiency and cytotoxicity of paclitaxel in vitro. Fu X; Lu Y; Guo J; Liu H; Deng A; Kuang C; Xie X J Liposome Res; 2019 Mar; 29(1):86-93. PubMed ID: 29671386 [TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related]
19. Microfluidic synthesis of multifunctional liposomes for tumour targeting. Ran R; Middelberg APJ; Zhao CX Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490 [TBL] [Abstract][Full Text] [Related]
20. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]